Korea stings GSK in first reverse payment case
Tuesday, 25 October 2011
Gareth Corfield
UK pharmaceutical company GlaxoSmithKline has been fined by South Korea’s Fair Trade Commission for colluding to shut out competition in the country’s medical market.
Subscription required to view this article
This content can only be accessed by GCR subscribers.
A subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current print and online content.
Please note: If you would like online access to all archived content, you will need a Premium subscription.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top